4-Iodo-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole, 97%, 10g

2'-Deoxyguanosine-5'-monophosphoric acid disodium salt, 95.0%, 5g

6-Fluorosalicylic acid, 97.0%, 5g

6-Methoxy-1H-indazol-3-amine, 95.0%, 1g

2-Methylpiperidin-4-ol, 95.0%, 1g

Ethyl trifluoropyruvate, 97.0%, 25g

Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)-4-pyrimidinyl]-, 50mg

5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 25g

n-Heptane, min. 95%, for synthesis, 100 ml, glass packaging

2-Bromo-5-fluorophenylacetonitrile, 95.0%, 10g

3-Fluoro-5-(pentafluorosulfur)benzamide, 5g

(2S,5S)-ethyl 5-hydroxypiperidine-2-carboxylate (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate, 98%, 1g

1-Chloro-4-(2,2,2-trifluoroethyl)benzene, 95.0%, 5g